Literature DB >> 30587051

Mucoepidermoid Carcinoma of the Gallbladder: A Case-Based Study of an Extremely Rare Tumor Highlighting the Role of Immunohistochemical Profiling.

Yashaswini Nallacheruvu1, Kavita Gaur1, Puja Sakhuja1, Anil Kumar Agarwal1, Siddharth Srivastava1.   

Abstract

Mucoepidermoid carcinoma (MEC) is rarely reported in the hepatobiliary system. In this article, we detail the first case of MEC arising from the gallbladder, presenting in a 50-year-old male. Imaging and gross examination showed a large mass in the gallbladder fossa infiltrating the liver. This microscopically displayed the classical morphology of MEC, which was confirmed on dual immunostain for p63 and CK7 and histochemical staining for mucin. MUC and p53 immunoexpression patterns suggested a poor prognosis. The patient succumbed to the disease with liver metastasis within 6 months. The cytomorphology of the metastatic lesion is also presented. Differences in the stem cell niches in the gallbladder and the rest of the biliary tract may possibly indicate the reason for the rarity of this tumor in the gallbladder. A possibly aggressive biological behavior of the gallbladder MEC necessitates its distinction from entities like the adenosquamous carcinoma.

Entities:  

Keywords:  carcinoma; gallbladder; immunohistochemistry; mucoepidermoid

Mesh:

Substances:

Year:  2018        PMID: 30587051     DOI: 10.1177/1066896918821436

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma.

Authors:  Ping Hou; Xiaoyan Su; Wei Cao; Liping Xu; Rongguiyi Zhang; Zhihao Huang; Jiakun Wang; Lixiang Li; Linquan Wu; Wenjun Liao
Journal:  Diagn Pathol       Date:  2021-04-08       Impact factor: 2.644

2.  Primary mucoepidermoid carcinoma of the intrahepatic bile duct: A case report.

Authors:  Kenichi Kato; Yasuyuki Hara; Akiko Nishida; Shuhei Suzuki; Hidenori Sato; Masahiro Chin; Eiji Hashizume
Journal:  Clin Case Rep       Date:  2022-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.